S. Seiter et al., Mitigation of delayed-type hypersensitivity reactions by a CD44 variant isoform v3-specific antibody: Blockade of leukocyte egress, J INVES DER, 113(1), 1999, pp. 11-21
In allergic alterations of human skin the majority of infiltrated leukocyte
s express CD44v3, but no other CD44 variant isoform, Vessel endothelium, to
o, is brightly stained with a CD44v3-specific antibody. Being concerned abo
ut therapeutic intervention, it became of importance to define whether expr
ession of CD44v3 on the endothelial cells or on the leukocytes or on both i
s of functional importance. As expression of CD44v3 in the mouse on activat
ed endothelium and on subpopulations of activated CD4(+) cells, B cells and
monocytes was similar to the expression in the human, we answered the ques
tion in a mouse delayed-type hypersensitivity model. The effect of anti-CD4
4v3 was compared with the effect of anti-CD44s and anti-CD44v10, both known
to suppress delayed-type hypersensitivity reactions. Anti-CD44v3 mitigated
the delayed-type hypersensitivity reaction in dinitrofluorobenzene sensiti
zed and challenged mice comparable with anti-CD44s and anti-CD44v10. The se
emingly similar effects of CD44 isoform-specific antibodies, however, resul
ted from a distinct modulation of response. Anti-CD44s mainly suppressed T
cell activation and interleukin-2 as well as interferon-gamma expression. A
nti-CD44v10 inhibited the activation of monocytes in the draining lymph nod
es and in the infiltrate, which led to a strong reduction in the proinflamm
atory cytokines tumor necrosis factor-a and interleukin-12 and in edema for
mation. AntiCD44v3 had only a weak effect on cytokine expression by isolate
d subpopulations of leukocytes, but suppressed cytokine production by helpe
r T cells when cocultured with antigen-presenting cells, i.e., blocked an i
nteraction between antigen-presenting cells and helper T cells. The dominat
ing effect of anti-CD44v3, however, relied on a blockade of leukocyte extra
vasation, As leukocytes transferred into dinitrofluorobenzene sensitized, a
nti-CD44v3-treated and lethally irradiated mice did not infiltrate the sens
itized skin, anti-CD44v3 most likely prevented leukocyte extravasation by b
locking CD44v3 on endothelial cells.